BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2 hours across 2,433 treated episodes (p<.05) Complete resolution of agitation was significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results